Vanguard Capital Wealth Advisors

Position in LLY — ELI LILLY & Co

CIK 1730578 DENVER, CO

Position in LLY

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$881,581

+$347,195 QoQ

Shares Held

735

+26.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

#3,251

of 4,605 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Vanguard Capital Wealth Advisors holds $3,241,473 across 6 Drug Manufacturers - General names. LLY ranks #2 (27.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	3,858	$970,827
2	LLY	ELI LILLY & Co This page	735	$881,581
3	BMY	Bristol Myers Squibb Co	9,127	$525,897
4	NVS	Novartis AG	2,050	$321,276
5	JNJ	Johnson & Johnson	1,191	$302,478
6	GILD	Gilead Sciences, Inc.	1,895	$239,414

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$881,581	735	+26.5%	Shares	Sole	2026-07-23
2026-03-31	$534,386	581	+1.0%	Shares	Sole	2026-04-21
2025-12-31	$617,941	575	-16.1%	Shares	Sole	2026-01-16
2025-09-30	$522,655	685	+0.3%	Shares	Sole	2025-10-30
2025-06-30	$532,418	683	+23.1%	Shares	Sole	2025-07-11
2025-03-31	$458,380	555	-1.8%	Shares	Sole	2025-04-11
2024-12-31	$436,180	565	0.0%	Shares	Sole	2025-02-18
2024-09-30	$500,556	565	0.0%	Shares	Sole	2024-10-25
2024-06-30	$511,539	565	0.0%	Shares	Sole	2024-08-08
2024-03-31	$439,547	565	+3.7%	Shares	Sole	2024-04-16
2023-12-31	$317,691	545	+10.1%	Shares	Sole	2024-02-05
2023-09-30	$265,879	495	—	Shares	Sole	2023-11-01
No filing history on record for this holder in this stock.